Mindray Medical International Ltd (NYSE:MR)

28.84
Delayed Data
As of Mar 03
 +0.84 / +3.00%
Today’s Change
25.90
Today|||52-Week Range
35.53
+9.24%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Mindray Medical International Ltd have a median target of 31.00, with a high estimate of 36.00 and a low estimate of 23.00. The median estimate represents a +7.49% increase from the last price of 28.84.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Mindray Medical International Ltd. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.52
Sales
$407.1M
Reporting Date
Mar 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.64%
 
 
 
 
 
 
Growthannually -16.28%
 
 
 
 
 
 

Sales

Growthquarterly 25.39%
 
 
 
 
 
 
Growthannually 9.81%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account